Tele-Rehabilitation in Adults With Cystic Fibrosis (NCT07500493) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Tele-Rehabilitation in Adults With Cystic Fibrosis
76 participantsStarted 2026-04-17
Plain-language summary
This study is a randomized controlled trial designed to evaluate the effectiveness of an 8-week tele-rehabilitation program in adults with cystic fibrosis. Cystic fibrosis is a chronic condition that affects the lungs and can lead to reduced muscle mass, physical weakness, frailty, and decreased quality of life.
Participants will be randomly assigned to either a tele-rehabilitation group or a usual care group. The tele-rehabilitation program includes supervised exercise sessions conducted remotely three times per week using video communication. The program combines aerobic and resistance training based on established rehabilitation guidelines.
The primary aim of the study is to assess the effect of the program
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18 years and older
* Confirmed diagnosis of cystic fibrosis
* Clinically stable condition with no acute exacerbation at the time of enrollment
* Ability to participate in an exercise program
* Access to a device with internet connection for tele-rehabilitation sessions
* Willingness to provide informed consent
Exclusion Criteria:
* Acute pulmonary exacerbation within the past 4 weeks
* Severe comorbidities that limit participation in exercise (e.g., unstable cardiovascular disease)
* Musculoskeletal or neurological conditions preventing safe exercise performance
* Cognitive impairment affecting ability to follow instructions
* Participation in another structured rehabilitation or clinical trial during the study period
* Pregnancy (if applicable based on your protocol)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Fat-Free Mass Index (FFMI)
Timeframe: Baseline to Week 8 (end of intervention)